Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin vs Tamsulosin and Placebo in BPH
NCT00359905Phase 3Completed
- Sponsor
- Recordati SpA
- Start
- May 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of silodosin in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Recordati SpA. Primary endpoint: International Prostate Symptom Score at 12 weeks. Started May 2006; status: completed.
02
Drugs
silodosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00359905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359905.